Pharmacoeconomic study of the degarelix drug use for treatment of hormone-dependent prostate cancer compared to gonadotropin-releasing hormone analogs

Por A. G. Tolkushin, N. L. Pogudina
Publicado em 2018-03-01

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus

Por A. G. Tolkushin, N. L. Pogudina
Publicado em 2018-11-01

Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach

Por A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya
Publicado em 2019-01-01

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD

Por E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov
Publicado em 2017-08-01

COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD

Por E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov
Publicado em 2017-08-01

COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA

Por N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov
Publicado em 2017-08-01